SCHEMBL7004334

SCHEMBL7004334

Cn1c(=O)n(CCCC(=O)O)c(=O)c2sc(N)nc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 4/20 0.55
▸ TNF P01375 5/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ LMNA P02545 2/20 0.38
▸ ADORA2B P29275 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ PNP P00491 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7005492 0.88 PDE4A (0.46) DPP4TNFADORA2BPDE4APDE4B
SCHEMBL6013380 0.84 TNF (0.60) DPP4TNF
SCHEMBL6880028 0.72 TNF (0.56) TNFCYP1A2ALDH1A1CYP2C19LMNA
SCHEMBL18460236 0.71 TNF (0.52) TNFCYP1A2ALDH1A1CYP2C19LMNA
SCHEMBL1729797 0.70 FABP4 (0.44) CYP1A2LMNATSHRNFKB1PMP22
SCHEMBL11293447 0.70 PDE4A (0.71) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL5688391 0.70 CYP1A2 (0.55) TNFCYP1A2ALDH1A1CYP2C19LMNA
SCHEMBL3771053 0.69 FABP4 (0.46) CYP1A2ALDH1A1CYP2C19LMNA
SCHEMBL30976974 0.69 APEX1 (0.47) CYP1A2LMNASMN1; SMN2
1-[4-Carboxypropyl]-3,7-Dimethylxanthine SCHEMBL5420399 0.68 ADORA2B (0.74) TNFCYP1A2LMNAADORA2BUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187838-B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors UNIV CALIFORNIA (US) 2003-08-06 — — EP claimed
Send feedback